To investigate the potential regulatory effects of PRDX5 on PAM-treated A549 lung cancer cells, MTT assays were performed, which showed that cell proliferation was significantly inhibited in the PRDX5 knockdown group compared with that in the control group (Figure 2C). Here, PRDX5 is linked to lung carcinoma.